Analyse India’s biomaterials ecosystem in comparison with global leaders like the EU, USA, and UAE. How can institutional coordination, R&D, and regulatory frameworks position India as a competitive and sustainable player in the global biomaterials market?

Question

PocketIAS · Accepted Answer

Global Benchmarking

USA: Leader in advanced biomaterials (medical implants, tissue engineering); strong R&D funding and translational pathways.
EU: Focus on sustainability, circular bioeconomy, and regulatory alignment with environmental standards.
UAE: Uses strategic partnerships and industrial clusters to scale high-value biomaterials rapidly.

India’s Current Scenario

Nascent biomaterials ecosystem with potential in biopolymers and biodegradable materials.
Fragmented institutional coordination; limited industry-academia collaboration.
Regulatory frameworks are evolving, lacking harmonization with global standards.

Strategic Pathways for Competitiveness

Strengthen inter-ministerial coordination (DBT, DST, CSIR) and establish biomaterials clusters.
Promote R&D via funding incentives, translational research, and patent facilitation.
Develop clear regulatory standards aligned with international best practices.
Focus on sustainable and biodegradable biomaterials to leverage cost-effectiveness and global environmental trends.

✍️ Practice Mode

Write. Evaluate. Improve. Repeat.

The model answer is ready.

Comments (0)